Virginia, October 21, 2025
Merck has announced the commencement of construction on a new $3 billion pharmaceutical center in Virginia, which is set to significantly impact North Carolina’s biotech sector. The facility aims to advance drug manufacturing and research, fostering innovation and collaboration within the region. With this development, Merck is positioning itself to enhance its capabilities in drug development and production, potentially bringing new opportunities and advancements to the local biotech community.
Elkton, Virginia – Merck’s $3 Billion Pharmaceutical Manufacturing Facility Under Construction
Elkton, Virginia – Merck & Co. has begun construction on a $3 billion pharmaceutical manufacturing facility in Elkton, Virginia. This 400,000-square-foot Center of Excellence is expected to generate over 500 full-time positions and approximately 8,000 construction jobs. The facility will enhance Merck’s capabilities in small-molecule manufacturing and testing, contributing to the company’s broader $70 billion investment in U.S. research, development, and capital projects.
This expansion is anticipated to influence North Carolina’s biotech sector significantly. Merck’s previous investments in the state include a $1 billion facility in Durham, completed in March 2025, which added nearly 400 full-time roles and approximately 4,000 construction jobs. The new facility in Virginia may lead to increased competition for talent and resources, potentially affecting North Carolina’s biotech industry dynamics.
Merck’s strategic investments in both Virginia and North Carolina underscore the company’s commitment to strengthening domestic pharmaceutical manufacturing and research capabilities. These developments are poised to have significant economic and industry-wide implications in the region.
FAQ
What is Merck’s new investment in Virginia?
Merck has begun construction on a $3 billion pharmaceutical manufacturing facility in Elkton, Virginia, which will serve as a Center of Excellence for small-molecule manufacturing and testing.
How many jobs will the new facility create?
The facility is expected to generate over 500 full-time positions and approximately 8,000 construction jobs.
What impact will this have on North Carolina’s biotech sector?
Merck’s expansion in Virginia may lead to increased competition for talent and resources, potentially affecting North Carolina’s biotech industry dynamics.
Has Merck made other investments in North Carolina?
Yes, Merck completed a $1 billion facility in Durham, North Carolina, in March 2025, adding nearly 400 full-time roles and approximately 4,000 construction jobs.
What is the purpose of Merck’s investments in these facilities?
Merck’s investments aim to strengthen domestic pharmaceutical manufacturing and research capabilities, contributing to the company’s broader $70 billion commitment to U.S. research, development, and capital projects.
Key Features of Merck’s $3 Billion Pharmaceutical Manufacturing Facility in Virginia
| Feature | Details |
|---|---|
| Investment Amount | $3 billion |
| Facility Size | 400,000 square feet |
| Job Creation | Over 500 full-time positions and approximately 8,000 construction jobs |
| Location | Elkton, Virginia |
| Purpose | Enhance small-molecule manufacturing and testing capabilities |
| Part of Merck’s Broader Investment | $70 billion commitment to U.S. research, development, and capital projects |
Deeper Dive: News & Info About This Topic
HERE Resources
Author: Construction NC News
The NORTH CAROLINA STAFF WRITER represents the experienced team at constructionncnews.com, your go-to source for actionable local news and information in North Carolina and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as the North Carolina Build Expo, major infrastructure projects, and advancements in construction technology showcases. Our coverage extends to key organizations like the Associated Builders and Contractors of the Carolinas and the North Carolina Home Builders Association, plus leading businesses in construction and legal services that power the local economy such as CMiC Global and Womble Bond Dickinson LLP. As part of the broader network, including constructioncanews.com, constructionnynews.com, and constructiontxnews.com, we provide comprehensive, credible insights into the dynamic construction landscape across multiple states.
